Skip to content 
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing. more
| Time Frame | BBP | S&P500 |
|---|---|---|
| 1-Week Return | -3.51% | 2.27% |
| 1-Month Return | -5.07% | 0.84% |
| 3-Month Return | 7.99% | 5.5% |
| 6-Month Return | 15.38% | 10.38% |
| 1-Year Return | 48.93% | 20.04% |
| 3-Year Return | 75.72% | 69.7% |
| 5-Year Return | 83.08% | 72.53% |
| 10-Year Return | 200.86% | 250.71% |
| Stock name | Ticker | Weight |
|---|---|---|
 Crinetics Pharmaceuticals Inc | CRNX | 3.25% |
 Kiniksa Pharmaceuticals International Plc | KNSA | 2.02% |
 Verastem Inc | VSTM | 1.99% |
 Omeros Corp | OMER | 1.83% |
 Nuvation Bio Inc | NUVB | 1.82% |
 Precigen Inc | PGEN | 1.79% |
 Protagonist Therapeutics Inc | PTGX | 1.69% |
 ACADIA Pharmaceuticals Inc | ACAD | 1.69% |
 Xeris Biopharma Holdings Inc | XERS | 1.66% |
 Bridgebio Pharma Inc | BBIO | 1.65% |
 Liquidia Corp | LQDA | 1.63% |
 BeOne Medicines Ltd | BGNE | 1.63% |
 Regeneron Pharmaceuticals Inc | REGN | 1.62% |
 Halozyme Therapeutics Inc | HALO | 1.6% |
 Rhythm Pharmaceuticals Inc | RYTM | 1.6% |
 Arrowhead Pharmaceuticals Inc | ARWR | 1.57% |
 Immunocore Holdings PLC | IMCR | 1.57% |
 Geron Corp | GERN | 1.56% |
 Neurocrine Biosciences Inc | NBIX | 1.55% |
 Moderna Inc | MRNA | 1.55% |
 Ligand Pharmaceuticals Inc | LGND | 1.55% |
 Rigel Pharmaceuticals Inc | RIGL | 1.55% |
 Krystal Biotech Inc | KRYS | 1.54% |
 Ascendis Pharma A/S | ASND | 1.54% |
 Iovance Biotherapeutics Inc | IOVA | 1.54% |
 Roivant Sciences Ltd | ROIV | 1.54% |
 Arcutis Biotherapeutics Inc | ARQT | 1.54% |
 Cytokinetics Inc | CYTK | 1.53% |
 Incyte Corp | INCY | 1.52% |
 Mirum Pharmaceuticals Inc | MIRM | 1.52% |
 Denali Therapeutics Inc | DNLI | 1.5% |
 Agios Pharmaceuticals Inc | AGIO | 1.49% |
 Travere Therapeutics Inc | TVTX | 1.47% |
 Amgen Inc | AMGN | 1.46% |
 Vertex Pharmaceuticals Inc | VRTX | 1.45% |
 BioMarin Pharmaceutical Inc | BMRN | 1.45% |
 TG Therapeutics Inc | TGTX | 1.45% |
 Ultragenyx Pharmaceutical Inc | RARE | 1.43% |
 Syndax Pharmaceuticals Inc | SNDX | 1.43% |
 Zai Lab Ltd | ZLAB | 1.43% |
 BioCryst Pharmaceuticals Inc | BCRX | 1.42% |
 ADMA Biologics Inc | ADMA | 1.41% |
 Exelixis Inc | EXEL | 1.41% |
 ImmunityBio Inc | IBRX | 1.4% |
 Gilead Sciences Inc | GILD | 1.4% |
 Harmony Biosciences Holdings Inc | HRMY | 1.39% |
 Biogen Inc | BIIB | 1.39% |
 Insmed Inc | INSM | 1.39% |
 Kura Oncology Inc | KURA | 1.38% |
 Madrigal Pharmaceuticals Inc | MDGL | 1.37% |
 BioNTech SE | BNTX | 1.37% |
 Ironwood Pharmaceuticals Inc | IRWD | 1.37% |
 Sarepta Therapeutics Inc | SRPT | 1.36% |
 Theravance Biopharma Inc | TBPH | 1.36% |
 PTC Therapeutics Inc | PTCT | 1.35% |
 Zymeworks Inc | ZYME | 1.33% |
 CRISPR Therapeutics AG | CRSP | 1.3% |
 United Therapeutics Corp | UTHR | 1.29% |
 Tarsus Pharmaceuticals Inc | TARS | 1.29% |
 Aurinia Pharmaceuticals Inc | AUPH | 1.27% |
 Axsome Therapeutics Inc | AXSM | 1.23% |
 Ardelyx Inc | ARDX | 1.19% |
 Phathom Pharmaceuticals Inc | PHAT | 1.17% |
 Novavax Inc | NVAX | 1.12% |
 Ionis Pharmaceuticals Inc | IONS | 0.97% |
 Alnylam Pharmaceuticals Inc | ALNY | 0.97% |
 Legend Biotech Corp | LEGN | 0.71% |
 Cash/Cash equivalents | Cash.Cash.equivalents | 0.19% |
 OmniAb Inc | OmniAb.Inc | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
Virtus LifeSci Biotech Products ETF (BBP) share price today is $96.0525.
Yes, Indians can buy shares of Virtus LifeSci Biotech Products ETF (BBP) on Vested. To buy BBP from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Virtus LifeSci Biotech Products ETF (BBP) on Vested. You can start investing in Virtus LifeSci Biotech Products ETF (BBP) with a minimum investment of $1.
The 52-week high price of Virtus LifeSci Biotech Products ETF (BBP) is $105.21. The 52-week low price of Virtus LifeSci Biotech Products ETF (BBP) is $62.62.
The stock symbol (or ticker) of Virtus LifeSci Biotech Products ETF is BBP.
Yes, you can setup SIP in Virtus LifeSci Biotech Products ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of BBP on the Vested app.
The expense ratio of Virtus LifeSci Biotech Products ETF (BBP) is 0.79%.
Link copied 
